See every side of every news story
Published loading...Updated

Medtech mindset: BD plans to divest diagnostic, biosciences divisions

Summary by NJBIZ
Nearly three years after Beckon Dickinson spun off its diabetes care unit, the Franklin Lakes-based global medical technology company aims to slim down even further to focus on its core business. As part of a plan announced Feb. 5, BD seeks to divest its diagnostic and biosciences divisions and continue as a pure-play medtech company. Under the proposal, the “new BD” will concentrate on four segments. The company believes these pillars align wit…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

NJBIZ broke the news in on Monday, February 10, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.